FDA To Study Selenium Health Claim Consumer Perceptions
This article was originally published in The Tan Sheet
The agency plans to study whether label claim language for selenium misleads consumers on the benefits of the ingredient. Legal experts say with the proposed study, FDA seeks to influence possible regulations down the road and circumvent court rulings that have curbed the agency’s authority to limit supplement claims.
You may also be interested in...
Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.
The “Contract Manufacturing Arrangements for Drugs: Quality Agreements” draft guidance describes how parties involved in contract manufacturing of drugs can employ quality agreements to delineate their responsibilities and ensure drug quality, safety and efficacy.